Response Prediction for Chronic HCV Genotype 4 Patients to DAAs

International Journal of Advanced Computer Science and Applications - United Kingdom
doi 10.14569/ijacsa.2016.071223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Science and Information Organization

Related search

Impact of the IL-18 Gene Polymorphism in Response to Antiviral Therapy in Chronic HCV Genotype 4 Patients

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2014English

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

BMC Gastroenterology
MedicineGastroenterology
2012English

Interferon-Ë Rs12979860CC Genotype Predicts Sustained Virological Response to Therapy in Patients With Chronic Hepatitis C Genotype 4 but Enhances Hepatic Fibrosis

Medical Journal of Viral Hepatitis
2016English

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases
Infectious Diseases
2020English

Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C Genotype 4: A Non-Invasive Biochemical Analysis

Biosciences Biotechnology Research Asia
BiotechnologyAgronomyCrop ScienceDrug Discovery
2016English

Telaprevir-Based Triple Therapy for Re-Treatment Chronic HCV Patients With Genotype 1, Including the Null-Response: A Single Center Experience From Turkey

Virology: Research and Reviews
2017English

Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease

Hepatitis Monthly
HepatologyInfectious Diseases
2012English

Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype

PLoS ONE
Multidisciplinary
2008English

The “Real-World” Efficacy and Safety of DAAs for the Treatment of HCV Patients Throughout Japan

Journal of Gastroenterology
Gastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy